The specialist polymer maker has raised its full-year profit guidance and set out five-year financial targets centred on margins and cash returns.
Victrex (LSE:VCT), the FTSE 250 manufacturer of high-performance PEEK polymers, has given investors two significant updates in recent weeks. A pre-close trading statement in September lifted profit expectations for the year to 30 September 2026, and a Capital Markets event later the same month laid out a new strategy and medium-term targets. The most recent regulatory filing, on 5 October, was a notification of a change in a major shareholding, as investors continue to reassess the company's prospects.
Profit guidance raised
In its pre-close update on 9 September, Victrex said momentum continued into the fourth quarter, with Revenue growing across key end markets and all regions. It now expects Underlying Profit before tax for financial 2026 of £45m to £47m, up from its previous range of £42m to £44m. Growth was led by Aerospace, Value Added Resellers and Electronics, and the company highlighted solid growth in Asia Pacific.
Chief executive Dr James Routh said fourth-quarter momentum had held up, allowing the group to raise its expectations. The company also confirmed that its 10% headcount reduction is complete and should deliver at least £10m of annualised savings in financial 2027. The divestment of Kleiss Gears completed in August, with an expected one-off loss of about £3m.
New targets from the capital markets event
At its capital markets event on 24 September, Victrex described itself as the global leader in PEEK, with more than 45% Market Share by volume, and pointed to its vertically integrated, largely Western-based Manufacturing as a competitive barrier. Its strategy is built around three themes: transforming into a simpler and more decentralised business, growing in high-value applications, and optimising efficiency and margins.
The company set targets for the five years to financial 2031. These include mid-single-digit organic revenue growth a year, a gross Margin of around 50% and an Operating Margin in the mid-20s, driven mainly by self-help measures. It is aiming for average operating cash conversion above 90% and total Capital Expenditure of about 5–8% of annual revenue.
A sharper focus on cash returns
The capital allocation policy is perhaps the most notable shift. Victrex expects to generate about £250m of cumulative levered free Cash Flow over the period, and aims to return at least 75% of it to shareholders, while keeping Leverage below one times net Debt to EBITDA. For financial 2026, the company set out an ordinary Dividend of 30p per share, including a final dividend of 16.58p, and is targeting Earnings cover of about two times by financial 2031.
For the FTSE 250, Victrex is one of a small group of UK-listed speciality materials companies with heavy exposure to industrial, aerospace and medical end markets. Its shares have been weighed down in recent years by weaker Demand and pressure on margins, so the combination of a guidance upgrade and explicit long-term targets gives investors clearer benchmarks against which to judge management's progress.
Victrex's targets rely heavily on self-help measures rather than a solid market recovery, which management argues makes them more within its own control. Delivery on cost savings from the completed headcount reduction will be an early test of that approach.
The next milestone will be the full-year results for the year to September 2026, which should confirm whether profit has landed within the upgraded range and provide the first update against the new framework. Investors are also likely to watch for progress in medical applications and any further evidence of a recovery in industrial demand.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...